BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. ✅
Go to Publication ✅
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21 Pub: 2015 Apr Epub: Authors Shadnoush M , Hosseini RS , Khalilnezhad A , Navai L , Goudarzi H , Vaezjalali M , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8 Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y , |
|
|
Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. ✅
Go to Publication ✅
Anaerobe (Anaerobe ) Vol: 18 Issue 1 Pages: 14-8 Pub: 2012 Feb Epub: 2011 Nov 26 Authors Odamaki T , Sugahara H , Yonezawa S , Yaeshima T , Iwatsuki K , Tanabe S , Tominaga T , Togashi H , Benno Y , Xiao JZ , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Adhesive <i>Bifidobacterium</i> Induced Changes in Cecal Microbiome Alleviated Constipation in Mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1721 Pub: 2019 Epub: 2019 Aug 13 Authors Wang L , Chen C , Cui S , Lee YK , Wang G , Zhao J , Zhang H , Chen W , |
|
|
Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: Issue Pages: Pub: 2020 Apr 29 Epub: 2020 Apr 29 Authors Chen Y , Jin Y , Stanton C , Paul Ross R , Zhao J , Zhang H , Yang B , Chen W , |
|
|
Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: Issue Pages: Pub: 2020 Nov 22 Epub: 2020 Nov 22 Authors Xu H , Ma C , Zhao F , Chen P , Liu Y , Sun Z , Cui L , Kwok LY , Zhang H , |
|
|
Bifidobacterium pseudocatenulatum Ameliorates DSS-Induced Colitis by Maintaining Intestinal Mechanical Barrier, Blocking Proinflammatory Cytokines, Inhibiting TLR4/NF-?B Signaling, and Altering Gut Microbiota. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 5 Pages: 1496-1512 Pub: 2021 Feb 10 Epub: 2021 Jan 29 Authors Chen Y , Yang B , Stanton C , Ross RP , Zhao J , Zhang H , Chen W , |
|
|
Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome. ✅
Go to Publication ✅
Microbiology spectrum (Microbiol Spectr ) Vol: Issue Pages: e0085921 Pub: 2021 Oct 6 Epub: 2021 Oct 6 Authors Liu A , Ma T , Xu N , Jin H , Zhao F , Kwok LY , Zhang H , Zhang S , Sun Z , |
|
|
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , |
|
|
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. ✅
Go to Publication ✅
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Effect of Probiotic Yogurt Supplementation(Bifidobacterium animalis ssp. lactis BB-12) on Gut Microbiota of Female Taekwondo Athletes and Its Relationship with Exercise-Related Psychological Fatigue. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 11 Issue 6 Pages: Pub: 2023 May 26 Epub: 2023 May 26 Authors Zhu J , Zhu Y , Song G , |
|
|
Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro. ✅
Go to Publication ✅
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: Issue Pages: Pub: 2023 Aug 26 Epub: 2023 Aug 26 Authors Araujo LDC , da Silva RAB , Silva CMPC , Salvador SLS , Messora MR , Furlaneto FAC , Mastrange MDA , Pucinelli CM , da Silva LAB , |
|
|
Mouse intestinal microbiome modulation by oral administration of a GABA-producing Bifidobacterium adolescentis strain. ✅
Go to Publication ✅
Microbiology spectrum (Microbiol Spectr ) Vol: 12 Issue 1 Pages: e0258023 Pub: 2024 Jan 11 Epub: 2023 Nov 22 Authors Tamés H , Sabater C , Royo F , Margolles A , Falcón JM , Ruas-Madiedo P , Ruiz L , |
|
|
The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. ✅
Go to Publication ✅
Data in brief (Data Brief ) Vol: 19 Issue Pages: 1025-1029 Pub: 2018 Aug Epub: 2018 May 24 Authors Jena PK , Sheng L , Nagar N , Wu C , Barile D , Mills DA , Wan YY , |
|
|
Bifidobacterium adolescentis Isolated from Different Hosts Modifies the Intestinal Microbiota and Displays Differential Metabolic and Immunomodulatory Properties in Mice Fed a High-Fat Diet. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 13 Issue 3 Pages: Pub: 2021 Mar 21 Epub: 2021 Mar 21 Authors Wang B , Kong Q , Cui S , Li X , Gu Z , Zhao J , Zhang H , Chen W , Wang G , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
